Hearing News Watch

MILAN, ITALY — Amplifon, parent company of Miracle-Ear and a global leader in hearing care services, today announced the appointment of Dr. Nicholas Reed to the newly created role of Vice President of Audiology Innovation and Research. In this role, Dr. Reed will oversee Amplifon’s research initiatives and support the company’s broader efforts in audiology and hearing health. He joins

AMSTERDAM, THE NETHERLANDS — Norgine B.V. announced that Swissmedic has granted marketing authorization for PEDMARQSI® (sodium thiosulfate solution for infusion) for the prevention of cisplatin-induced ototoxicity (hearing loss) in patients aged 1 month to <18 years with localized, non-metastatic solid tumors. The approval provides an authorized treatment option in an area of significant unmet medical need for children receiving cisplatin chemotherapy.

MONTPELLIER, FRANCE — Sensorion on Monday reported updated six-month efficacy data from Cohort 2 of its Phase 1/2 Audiogene trial evaluating SENS-501, while also providing a development update on its GJB2 gene therapy program, GJB2-GT (SENS-601). The company said the six-month follow-up data from Cohort 2 showed sustained early efficacy signals in two of three patients treated with the higher

OKLAHOMA CITY, OK — When people cannot hear their own voices, their tongue movements become less precise during speech, according to new research from the University of Oklahoma. The findings provide direct evidence of how hearing contributes to speech production and may help inform therapies for individuals with hearing loss or those affected by conditions such as tongue cancer. The

Organizers of the International Congress of Hearing Care Professionals (EUHA 2026) have announced that The Netherlands will serve as the partner country for this year’s event, taking place October 14–16, 2026, in Hanover, Germany. The partner country concept includes a range of program elements and activities that will be featured throughout the three-day congress. Planned highlights include expert presentations from

GN Store Nord A/S announced that it has entered into a definitive agreement to sell its Hearing business to Amplifon S.p.A., a global hearing care retailer. The transaction values the Hearing business at DKK 17.0 billion (~$2.5 billion USD)1 on a cash-free and debt-free basis. The deal will be settled with DKK 12.6 billion (~$1.85 billion USD)2 in cash and

For people with severe to profound hearing loss, cochlear implants can provide access to sound that may significantly improve communication and quality of life. However, outcomes vary widely among recipients, and understanding which patients are most likely to benefit remains an important clinical question. A research project led by Yingying Wang at the University of Nebraska–Lincoln examined how brain activity

SAN DIEGO, CALIFORNIA — Ting Therapeutics Inc. announced plans to co-host a special event focused on hearing health innovation and investment ahead of the BIO International Convention (BIO 2026), scheduled to take place this June in San Diego. The event, titled “Invest in Hearing”, will feature a Hearing Startups Showcase and investor reception on Sunday, June 21, 2026, beginning at 2:30

SOMERSET, NEW JERSEY — Oticon, Inc., a hearing aid manufacturer and part of the Demant Group, announced the appointment of Michael Lamberson as President, U.S. Wholesale, effective March 2, 2026. Lamberson succeeds Ty Lee, who served as interim President during the leadership transition while continuing in his role as Group President, Demant North America. In his new role, Lamberson will

MILAN, ITALY — Amplifon S.p.A., a global provider of hearing care solutions and services, has reported consolidated revenues of €2.4 billion (~$2.6B USD) for fiscal year 2025, representing growth of 1.7% at constant exchange rates compared with 2024. The company cited improving organic growth in the second half of the year despite overall market expansion remaining below historical levels. The